Your session is about to expire
← Back to Search
Other
Antipsychotic Drugs for Schizophrenia
N/A
Waitlist Available
Research Sponsored by National Center for Research Resources (NCRR)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Meet DSM-IV criteria for schizophrenia, any type, or schizoaffective disorder
No medication changes for 2 weeks prior to and during the period of study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Study Summary
This trial is comparing how two antipsychotic drugs affect levels of glucose and insulin in the body. People with schizophrenia are more likely to have problems with blood sugar regulation, and it's possible that antipsychotic drugs may make this worse.
Who is the study for?
This trial is for individuals with schizophrenia or schizoaffective disorder who are currently on olanzapine, risperidone, haloperidol, or another typical antipsychotic. They must not have had medication changes for two weeks before the study and be able to give informed consent.Check my eligibility
What is being tested?
The study examines how risperidone and olanzapine affect blood sugar control by influencing glucose and insulin levels in the body. It aims to understand if these medications contribute to diabetes risk in people with schizophrenia.See study design
What are the potential side effects?
Potential side effects may include changes in glucose regulation leading to increased risk of type 2 diabetes, weight gain, and possibly other metabolic complications associated with antipsychotic treatments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been diagnosed with schizophrenia or schizoaffective disorder.
Select...
I haven't changed my medications in the last 2 weeks and won't during the study.
Select...
I am currently taking medications like olanzapine or risperidone.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Find a Location
Who is running the clinical trial?
Washington University School of MedicineOTHER
1,928 Previous Clinical Trials
2,297,088 Total Patients Enrolled
16 Trials studying Schizophrenia
1,065 Patients Enrolled for Schizophrenia
Janssen, LPIndustry Sponsor
158 Previous Clinical Trials
304,958 Total Patients Enrolled
26 Trials studying Schizophrenia
7,156 Patients Enrolled for Schizophrenia
National Center for Research Resources (NCRR)Lead Sponsor
537 Previous Clinical Trials
317,016 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with schizophrenia or schizoaffective disorder.I haven't changed my medications in the last 2 weeks and won't during the study.I am currently taking medications like olanzapine or risperidone.
Research Study Groups:
This trial has the following groups:Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the elderly population being considered for participation in this experiment?
"Patients aged 18 to 60 are eligible for this trial, while individuals younger than that should consider the 46 studies specifically designed for them. Meanwhile, those older than 65 may be interested in looking at the 164 trials tailored to their age group."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger